Insider · CIK 0001592380
Clay Thorp
Files at CLSD (Clearside Biomedical, Inc.). First filing Feb 24, 2025, latest Feb 24, 2025.
In brief
Clay Thorp files SEC Form 4 as director at CLSD (Clearside Biomedical, Inc.). Since Feb 24, 2025, Clay Thorp has reported 1 open-market buy worth $14k and 0 open-market sells worth $0, the latest filed on Feb 24, 2025.
A track record needs three past buys with six months of prices behind them; Clay Thorp has 0, so none is measured yet.
The newest scored trade: bought $14k of CLSD on Feb 24, 2025, filed Feb 24, 2025, scored 18 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | CLSDbuy Clearside Biomedical, Inc. | $14k 15,000 shares | +9% | - |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 24, 2025 | CLSD Clearside Biomedical, Inc. | POpen-market purchase Common Stock | +15,000 | $0.92 | $14k | 176,141 | Feb 24, 2025 |
Questions about Clay Thorp
Answered from the filings on this page, as of the latest one.
Is Clay Thorp buying or selling?
Not in the last 12 months. Clay Thorp's latest open-market trade on SEC Form 4 was bought $14k of CLSD on Feb 24, 2025.
How did Clay Thorp's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Clay Thorp has 0.
Where does Clay Thorp file Form 4?
Clay Thorp has filed Form 4 at CLSD (Clearside Biomedical, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.